Table 3.
Treatment group | MDA (nmol/g) | NP-SH (nmol/g) | TP (g/l) |
---|---|---|---|
Control | 0.50±0.02 | 7.39±0.53 | 113.76±2.81 |
CCl4 | 4.82±0.29***a | 3.86±0.44***a | 49.11±1.82***a |
A. javanica (100 mg) + CCl4 | 2.77±0.10***b | 5.67±0.47*b | 67.86±2.94***b |
A. javanica (200 mg) + CCl4 | 1.79±0.14***b | 6.16±0.40**b | 82.23±4.44***b |
Silymarin (10 mg) + CCl4 | 1.37±0.16***b | 6.52±0.31***b | 91.81±4.08***b |
All values represent mean±SEM
P<0.05
P<0.01
P<0.001; ANOVA, followed by Dunnet's multiple comparison test.
As compared with normal group.
As compared with CCl4-only group.